HIV trials recruiting in California

All HIV trials nationally

Cities in California

Recruiting trials in California

• A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
  NCT07266831 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
  NCT07044297 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female) · California: Los Angeles, San Francisco
• A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
  NCT05719441 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: Los Angeles, San Diego, San Francisco, Torrance
• A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
  NCT07202546 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Bakersfield, Palm Springs, West Hollywood
• A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
  NCT07390955 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · California: San Francisco
• A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
  NCT07143968 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla, San Francisco
• A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
  NCT07650916 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · California: Bakersfield, Los Angeles, San Diego
• A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
  NCT07569029 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · California: San Francisco
• ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
  NCT06128304 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 64 Years · Sex: Female · California: La Jolla
• An Integrated Intervention Using a Pill Ingestible Sensor System
  NCT06480578 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
  NCT06444360 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 24 Years · Sex: All (male and female) · California: Los Angeles
• CAR-T Cells for HIV Infection
  NCT04648046 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Sacramento, San Francisco
• CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM
  NCT07213258 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: Male · California: San Francisco
• CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS
  NCT06252402 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, San Diego
• California MEPS Hub
  NCT07433985 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 59 Years · Sex: Male · California: Oakland, Riverside
• Cannabis Use, Cognition, and the Endocannabinoid System in HIV
  NCT04883255 · Phase: Early Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: San Diego
• Cefixime Clinical Trial
  NCT04958122 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
  NCT05488431 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · California: Los Angeles, San Francisco
• Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
  NCT06665646 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · California: San Francisco
• Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
  NCT06796686 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · California: San Francisco
• Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
  NCT05663502 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla, San Francisco
• Collection of Blood for Multiple Collaborative Studies
  NCT01336855 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
  NCT04855773 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: All (male and female) · California: San Francisco
• Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
  NCT05514899 · Phase: Phase 2 · Ages: 21 Years to 70 Years · Sex: All (male and female) · California: San Diego
• Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
  NCT06071767 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego
• Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically
  NCT06370780 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
  NCT07087145 · Phase: Not specified · Ages: 35 Years and older · Sex: All (male and female) · California: San Francisco
• Imaging Immune Activation in HIV by PET-MR
  NCT03684655 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
  NCT05077527 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte
• Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
  NCT04949464 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 80 Years · Sex: All (male and female) · California: La Jolla
• Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
  NCT07473778 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Beverly Hills, Los Angeles, San Diego, West Hollywood
• Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
  NCT06263426 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Sacramento, San Diego, San Francisco
• Menopausal HT for Women Living With HIV (HoT)
  NCT06856174 · Phase: Phase 4 · Ages: 40 Years to 60 Years · Sex: Female · California: Los Angeles, San Diego, San Francisco, Torrance
• Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles County
  NCT07467018 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Santa Monica
• Multidisciplinary Low-Barrier and Mobile HIV Care to Improve Retention and Viral Suppression: Stakeholder-Engaged Design and Evaluation
  NCT05887557 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: All (male and female) · California: Oakland, San Francisco
• Naltrexone for Overdose Prevention
  NCT06633900 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)
  NCT07683117 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Del Mar
• People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
  NCT06055868 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
  NCT05674656 · Phase: Phase 1, Phase 2 · Ages: 6 Years to 12 Years · Sex: All (male and female) · California: Long Beach
• Positive Peers Intervention Clinical Trial
  NCT06388109 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 34 Years · Sex: All (male and female) · California: Van Nuys
• Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care
  NCT05241990 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego
• Prevention Ambassadors: Intervention to Promote HIV Service Engagement in the Networks of SSP Clients
  NCT06848686 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego
• Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial
  NCT07125235 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: Male · California: San Francisco
• SCOPE Analytic Treatment Interruption Protocol
  NCT04359186 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
  NCT00187512 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Safety Study of MucoCept-CVN
  NCT07181486 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: Female · California: San Francisco
• Sexual Health Advocacy for Guys - a Text Messaging-based HIV Prevention Program for Guys Who Are Into Guys
  NCT06230367 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 22 Years · Sex: Male · California: San Clemente
• Small Trial of Alendronate Impact on the Reservoir of HIV
  NCT07216794 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: San Francisco
• Study of GS-0415 and How It Works in People With HIV
  NCT07719491 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Los Angeles
• Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
  NCT07682961 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
  NCT07040319 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 45 Years · Sex: Female · California: Los Angeles
• T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
  NCT06343311 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Sacramento
• Teamwork Makes the Dream Work
  NCT05866523 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Loma Linda
• Testing a Gender-inclusive HIV Prevention Program
  NCT06586151 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 18 Years · Sex: Male · California: San Clemente
• Text Education About Cardiovascular Health and HIV (TEACH-HIV)
  NCT05642858 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · California: San Francisco
• The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women
  NCT07284082 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · California: San Francisco
• The Use of Leukapheresis to Support HIV Pathogenesis Studies
  NCT01161199 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
  NCT01202305 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: San Francisco
• This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.
  NCT07089836 · Phase: Not specified · Ages: 13 Years and older · Sex: All (male and female) · California: Lancaster, Los Angeles
• Trial of Ixazomib for Kaposi Sarcoma
  NCT04305691 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego, San Francisco
• Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
  NCT07293559 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · California: Los Angeles, San Diego
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
  NCT02140255 · Phase: Phase 1, Phase 2 · Ages: Up to 48 Hours · Sex: All (male and female) · California: La Jolla, Los Angeles
• Women Focused Encounters for Resilience Independence Strength and Eudaimonia
  NCT06216600 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · California: San Diego
• Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement
  NCT05509959 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · California: La Jolla